TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 4 | -9 | 19 | 5 | 26 | 8 | 
| P | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 | |||
| S | %ret | 1 | 1 | 1 | -2 | -6 | -14 | -20 | -23 | -37 | -17 | 
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/1/20 08:34  | 8/26/20  | FBIO | Fortress Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | NY | D | P | 300 | 18.00 | 0 | 17 | New | 17 | D | |||||||||||||||
11/10/14 16:23  | 11/6/14  | CNDO | Coronado Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | MA | D | P | 40 | 1.61 | 0 | 25 | 83 | 55 | D | |||||||||||||||
12/29/06 18:28  | 12/29/06  | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | NY | D | M.d | 10 | 1.92 | 5 | 5 | 0 | D | 16 | -7 | -2 | 11 | -6 | -8 | -2 | -3 | -2 | -6 | -14 | -20 | -23 | -37 | ||
12/29/06 18:28  | 12/29/06  | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | NY | D | S.d | -93 | 13.23 | 5 | -7 | -100 | 0 | D | 16 | -7 | -2 | 11 | -6 | -8 | -2 | -3 | -2 | -6 | -14 | -20 | -23 | -37 | |
4/26/05 17:29  | 2/2/01  | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hoenlein Malcolm | NY | D | P.d | 19 | 9.62 | 4 | 2 | New | 2 | D | 985 | -25 | 22 | -9 | 9 | 1 | 4 | 4 | 3 | 4 | -9 | 19 | 5 | 26 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |